Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
09/2002
09/18/2002CN1370169A Substituted heterocycle fused gamma-carbolines
09/18/2002CN1370144A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/12/2002WO2002070533A2 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
09/12/2002WO2002070516A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
09/12/2002WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof
09/12/2002WO2002070507A2 Glycorticoid receptor antagonists for treatment of diabetes
09/12/2002US20020128270 Treating stroke, arhtritis, cancer, tissue ulceration, decubitis ulcer, restenosis, periodontal disease, epidermolysis bullosa, scleritis, psoriasis, AIDS, sepsis, and septic shock.
09/12/2002CA2439849A1 Antagonists of mcp-1 function and methods of use thereof
09/12/2002CA2439836A1 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
09/11/2002EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators
09/11/2002EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
09/10/2002US6448277 VEGF receptor tyrosine kinase inhibitors
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
09/06/2002WO2002055059A3 Method for preparing submicron particle suspensions
09/06/2002CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
09/05/2002US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC
09/05/2002US20020123494 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death
08/2002
08/29/2002WO2002066617A1 Method for detecting a risk of hypertension and uses thereof
08/29/2002WO2002066470A1 Substituted alkylamine derivatives and methods of use
08/29/2002WO2002066467A1 Dibenzo[c]chromen-6-one derivatives as anti-cancer agents
08/29/2002WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors
08/29/2002US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them
08/29/2002US20020119994 LFA-1 Antagonist compounds
08/28/2002EP1233962A2 Novel heterocyclic compounds and their use as medicines
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002CN1089761C Sidechain-bearing texanes and its preparing process
08/27/2002US6441196 Processes and novel intermediates for 11-oxa prostaglandin synthesis
08/27/2002US6441186 Epothilone analogs
08/27/2002US6441173 Process for preparing indane carboxylate and cyclopentano [6] pyridine derivatives
08/22/2002WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors
08/22/2002US20020115859 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials
08/22/2002US20020115711 Dibenzo[c]chromen-6-one derivatives as anti-cancer agents
08/21/2002EP0668862B1 Oxidation of glycoside substituted taxanes to taxol or taxol precursors and taxane compounds formed as intermediates
08/20/2002US6437045 Powder coating of carboxyl polyester or (poly)methacrylate and cycloaliphatic polyepoxide
08/20/2002US6436989 Prodrugs of aspartyl protease inhibitors
08/20/2002CA2203463C New diosmetin acids and esters, and the pharmaceutical compounds that contain them
08/15/2002WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors
08/15/2002WO2002062781A1 Preparation of isocoumarin derivatives and intermediates for the synthesis thereof
08/15/2002WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
08/15/2002US20020110874 Recombinant production of novel polyketides
08/15/2002CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
08/14/2002EP1230238A2 Process for the preparation of fumagillin
08/14/2002EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/14/2002EP1230219A1 Aromatic sulfons hydroxamic acid metalloprotease inhibitor
08/14/2002EP1230216A1 Positive modulators of nicotinic receptor agonists
08/13/2002US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/13/2002US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents
08/08/2002WO2002060890A1 Novel physiologically active substances
08/08/2002WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
08/08/2002WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/08/2002WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
08/08/2002WO2001077134A3 Process for the preparation of 6-o-propargyl erythromycin derivatives
08/08/2002CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
08/08/2002CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/07/2002EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain
08/07/2002EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity
08/07/2002EP1228058A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
08/07/2002CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents
08/07/2002CN1362958A C7 carbonate substituted taxanes as antitumor agents
08/07/2002CN1362957A C17 heterosubustituted acetate taxanes as antitumor agents
08/07/2002CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents
08/07/2002CN1362955A C7 ester substituted taxanes as antitumor agents
08/07/2002CN1362876A C10 heterosubstituted acetate taxanes as antitumor agents
08/07/2002CN1362397A Dialkoyl-halogen phenyl substituted keto-enol
08/01/2002WO2002059114A1 Lfa-1 antagonist compounds
08/01/2002WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
08/01/2002US20020103387 Compounds which mimic the chemical and biological properties of discodermolide
08/01/2002US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002CA2435647A1 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
08/01/2002CA2429353A1 Lfa-1 antagonist compounds
07/2002
07/31/2002EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain
07/31/2002EP0888334B1 2-hetaroylcyclohexane-1,3-diones
07/31/2002CN1361769A Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) one
07/31/2002CN1361765A Inhibitors of aspartyl protease
07/25/2002WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors
07/24/2002EP1224197A1 Hygromycin derivatives
07/24/2002EP1224184A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same
07/24/2002EP0989114B1 N,n-disubstituted amic acid derivatives
07/24/2002EP0889041B1 Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
07/24/2002EP0741716B1 Delta 12,13 -iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
07/23/2002US6423710 Cyclic AMP-specific phosphodiesterase inhibitors
07/18/2002WO2002055059A2 Method for preparing submicron particle suspensions
07/18/2002US20020095061 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound
07/18/2002US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity
07/17/2002EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
07/16/2002US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds
07/16/2002US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or
07/16/2002US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase.
07/16/2002US6420387 Antitumor
07/16/2002US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/11/2002WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 120